COMPOUNDED WEGOVY ALTERNATIVES
Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what investors need to know
Are weight-loss jabs for dogs the next big thing? Scientists exploring new solutions for pet obesity
Hims & Hers Q2 revenue drop shakes stock—Hims crashes 11% after first-ever revenue decline, is the weight-loss drug hype finally fading?
Hims stock tanks over 20% after Wegovy deal collapse — why Novo Nordisk’s breakup over weight loss drugs is shaking up Wall StreetHims stock took a major hit after Novo Nordisk suddenly ended their Wegovy partnership, causing shares to drop over 20% in a single day. Th...23 Jun, 2025, 07.22 PM IST
Load More